During the last session, Mereo Biopharma Group Plc ADR (NASDAQ:MREO)’s traded shares were 1.03 million, with the beta value of the company hitting 0.83. At the end of the trading day, the stock’s price was $2.81, reflecting an intraday gain of 1.08% or $0.03. The 52-week high for the MREO share is $4.36, that puts it down -55.16 from that peak though still a striking 67.26% gain since the share price plummeted to a 52-week low of $0.92. The company’s market capitalization is $393.57M, and the average trade volume was 1.42 million shares over the past three months.
Mereo Biopharma Group Plc ADR (NASDAQ:MREO) trade information
Mereo Biopharma Group Plc ADR (MREO) registered a 1.08% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.08% in intraday trading to $2.81, hitting a weekly high. The stock’s 5-day price performance is 6.04%, and it has moved by -4.75% in 30 days. Based on these gigs, the overall price performance for the year is 150.89%.
Mereo Biopharma Group Plc ADR (MREO) estimates and forecasts
Statistics show that Mereo Biopharma Group Plc ADR has outperformed its competitors in share price, compared to the industry in which it operates. Mereo Biopharma Group Plc ADR (MREO) shares have gone up 59.66% during the last six months, with a year-to-date growth rate more than the industry average at 115.00% against 12.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 41.78%. While earnings are projected to return 68.75% in 2024.
MREO Dividends
Mereo Biopharma Group Plc ADR is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
